Biological Products, (No Diagnostic Substances)
132 stocks in Healthcare & Pharma · SIC 2836.
Company snapshot 2026-10-09 · Calculated market cap as of 2026-10-02 · USD
| Ticker | Company | Market Cap | Revenue (TTM) | Net Income (TTM) |
|---|---|---|---|---|
| AMGN | AMGEN INC | $220.18B | $38.09BTTM ended 2026-06-30 | $8.74BTTM ended 2026-06-30 |
| GILD | GILEAD SCIENCES, INC. | $182.89B | $30.46BTTM ended 2026-06-30 | −$3.24BTTM ended 2026-06-30 |
| MRNA | Moderna, Inc. | $75.43B | $2.23BTTM ended 2026-06-30 | −$3.15BTTM ended 2026-06-30 |
| RVMD | Revolution Medicines, Inc. | $44.13B | $0.00TTM ended 2025-12-31 | −$1.77BTTM ended 2026-06-30 |
| BIIB | BIOGEN INC. | $32.92B | $9.94BTTM ended 2026-03-31 | $1.37BTTM ended 2026-03-31 |
| EXEL | EXELIXIS, INC. | $14.36B | $2.44BTTM ended 2026-07-03 | $860.62MTTM ended 2026-07-03 |
| NBIX | NEUROCRINE BIOSCIENCES INC | $14.30B | $3.37BTTM ended 2026-06-30 | $705.50MTTM ended 2026-06-30 |
| HALO | HALOZYME THERAPEUTICS, INC. | $12.14B | $1.66BTTM ended 2026-06-30 | $413.60MTTM ended 2026-06-30 |
| TWST | Twist Bioscience Corp | $11.79B | $431.80MTTM ended 2026-06-30 | −$136.72MTTM ended 2026-06-30 |
| TECH | BIO-TECHNE Corp | $11.35B | $1.22BTTM ended 2026-06-30 | $181.86MTTM ended 2026-06-30 |
| APGE | Apogee Therapeutics, Inc. | $10.22B | — | −$294.37MTTM ended 2026-06-30 |
| RGEN | REPLIGEN CORP | $10.00B | $785.10MTTM ended 2026-06-30 | $41.54MTTM ended 2026-06-30 |
| IBRX | ImmunityBio, Inc. | $9.84B | $165.79MTTM ended 2026-06-30 | −$992.36MTTM ended 2026-06-30 |
| KRYS | Krystal Biotech, Inc. | $9.63B | $440.48MTTM ended 2026-06-30 | $241.46MTTM ended 2026-06-30 |
| KYMR | Kymera Therapeutics, Inc. | $9.16B | $105.00MTTM ended 2026-06-30 | −$299.60MTTM ended 2026-06-30 |
| PCVX | Vaxcyte, Inc. | $8.34B | — | −$1.06BTTM ended 2026-06-30 |
| IMVT | Immunovant, Inc. | $6.95B | — | −$538.22MTTM ended 2026-06-30 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $6.45B | $324.97MTTM ended 2026-06-30 | −$289.52MTTM ended 2026-06-30 |
| KOD | Kodiak Sciences Inc. | $6.19B | — | −$241.99MTTM ended 2026-06-30 |
| CGON | CG Oncology, Inc. | $6.06B | $6.23MTTM ended 2026-06-30 | −$224.38MTTM ended 2026-06-30 |
| SRRK | Scholar Rock Holding Corp | $5.62B | $0.00TTM ended 2026-06-30 | −$408.59MTTM ended 2026-06-30 |
| CRSP | CRISPR Therapeutics AG | $5.36B | $13.39MTTM ended 2026-06-30 | −$451.14MTTM ended 2026-06-30 |
| ADPT | Adaptive Biotechnologies Corp | $4.37B | $308.08MTTM ended 2026-06-30 | −$63.85MTTM ended 2026-06-30 |
| RLAY | Relay Therapeutics, Inc. | $4.05B | $10.35MTTM ended 2026-06-30 | −$286.04MTTM ended 2026-06-30 |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.31B | $606.33MTTM ended 2026-06-30 | −$46.48MTTM ended 2026-06-30 |
| DNLI | Denali Therapeutics Inc. | $3.28B | $3.60MTTM ended 2026-06-30 | −$511.45MTTM ended 2026-06-30 |
| BEAM | Beam Therapeutics Inc. | $2.52B | $156.03MTTM ended 2026-06-30 | −$86.52MTTM ended 2026-06-30 |
| ADMA | ADMA BIOLOGICS, INC. | $2.22B | $512.27MTTM ended 2026-06-30 | $168.96MTTM ended 2026-06-30 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | $2.20B | $54.86MTTM ended 2026-06-30 | −$518.88MTTM ended 2026-06-30 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $2.07B | $940.61MTTM ended 2026-06-30 | −$384.67MTTM ended 2026-06-30 |
| VCEL | Vericel Corp | $2.02B | $306.30MTTM ended 2026-06-30 | $24.22MTTM ended 2026-06-30 |
| VIR | Vir Biotechnology, Inc. | $1.91B | $303.23MTTM ended 2026-06-30 | −$251.68MTTM ended 2026-06-30 |
| NVAX | NOVAVAX INC | $1.75B | $413.80MTTM ended 2026-06-30 | −$247.73MTTM ended 2026-06-30 |
| TSHA | Taysha Gene Therapies, Inc. | $1.54B | $5.49MTTM ended 2026-06-30 | −$149.63MTTM ended 2026-06-30 |
| MAZE | Maze Therapeutics, Inc. | $1.48B | $2.50MTTM ended 2025-06-30 | −$133.59MTTM ended 2026-06-30 |
| GRML | Greenland Mines Ltd | $1.45B | — | −$21.77MTTM ended 2026-06-30 |
| INBX | Inhibrx Biosciences, Inc. | $1.44B | $0.00TTM ended 2026-06-30 | −$138.18MTTM ended 2026-06-30 |
| REPL | Replimune Group, Inc. | $1.27B | — | −$297.01MTTM ended 2026-06-30 |
| VOR | Vor Biopharma Inc. | $1.07B | — | $627.78MTTM ended 2026-06-30 |
| MGTX | MeiraGTx Holdings plc | $1.02B | $397.50MTTM ended 2026-06-30 | $78.98MTTM ended 2026-06-30 |
| GLUE | Monte Rosa Therapeutics, Inc. | $960.63M | $28.73MTTM ended 2026-06-30 | −$161.12MTTM ended 2026-06-30 |
| CGEM | Cullinan Therapeutics, Inc. | $935.07M | — | −$204.69MTTM ended 2026-06-30 |
| SANA | Sana Biotechnology, Inc. | $865.15M | — | −$211.82MTTM ended 2026-06-30 |
| DNA | Ginkgo Bioworks Holdings, Inc. | $841.75M | $132.42MTTM ended 2026-06-30 | −$290.80MTTM ended 2026-06-30 |
| ATTO | Attovia Therapeutics, Inc. | $812.14M | — | — |
| CADL | Candel Therapeutics, Inc. | $777.43M | — | −$88.53MTTM ended 2026-06-30 |
| FDMT | 4D Molecular Therapeutics, Inc. | $764.58M | $92.01MTTM ended 2026-06-30 | −$179.18MTTM ended 2026-06-30 |
| SLDB | Solid Biosciences Inc. | $748.43M | — | −$207.10MTTM ended 2026-06-30 |
| AURA | Aura Biosciences, Inc. | $626.38M | — | −$131.01MTTM ended 2026-06-30 |
| PRME | Prime Medicine, Inc. | $542.32M | $4.63MTTM ended 2025-12-31 | −$187.89MTTM ended 2026-06-30 |
| ALLO | Allogene Therapeutics, Inc. | $532.06M | $4.64MTTM ended 2026-06-30 | −$165.49MTTM ended 2026-06-30 |
| PROK | PROKIDNEY CORP. | $516.97M | $818.00KTTM ended 2026-06-30 | −$84.16MTTM ended 2026-06-30 |
| RGNX | REGENXBIO Inc. | $489.82M | $174.48MTTM ended 2026-06-30 | −$196.43MTTM ended 2026-06-30 |
| TECX | Tectonic Therapeutic, Inc. | $443.18M | — | −$85.79MTTM ended 2026-06-30 |
| KYTX | Kyverna Therapeutics, Inc. | $403.22M | — | −$152.64MTTM ended 2026-06-30 |
| ZURA | Zura Bio Ltd | $396.73M | — | −$85.74MTTM ended 2026-06-30 |
| EDIT | Editas Medicine, Inc. | $387.02M | $47.01MTTM ended 2026-06-30 | −$73.95MTTM ended 2026-06-30 |
| CCCC | C4 Therapeutics, Inc. | $386.30M | $35.04MTTM ended 2026-06-30 | −$101.42MTTM ended 2026-06-30 |
| AGEN | AGENUS INC | $375.02M | $132.69MTTM ended 2026-06-30 | $91.94MTTM ended 2026-06-30 |
| FENC | FENNEC PHARMACEUTICALS INC. | $362.24M | $59.22MTTM ended 2026-06-30 | −$3.25MTTM ended 2026-06-30 |
| SRZN | Surrozen, Inc./DE | $352.61M | $11.51MTTM ended 2026-06-30 | −$332.13MTTM ended 2026-06-30 |
| OCGN | Ocugen, Inc. | $339.11M | $4.58MTTM ended 2026-06-30 | −$81.81MTTM ended 2026-06-30 |
| ARTV | Artiva Biotherapeutics, Inc. | $331.96M | $0.00TTM ended 2025-12-31 | −$90.82MTTM ended 2026-06-30 |
| CABA | Cabaletta Bio, Inc. | $320.44M | — | −$181.32MTTM ended 2026-06-30 |
| LXEO | Lexeo Therapeutics, Inc. | $297.01M | — | −$87.27MTTM ended 2026-06-30 |
| IPSC | Century Therapeutics, Inc. | $291.53M | $109.16MTTM ended 2025-12-31 | −$109.79MTTM ended 2026-06-30 |
| XFOR | X4 Pharmaceuticals, Inc | $280.59M | $15.85MTTM ended 2026-06-30 | −$90.14MTTM ended 2026-06-30 |
| SABS | SAB Biotherapeutics, Inc. | $278.42M | $0.00TTM ended 2025-12-31 | −$12.78MTTM ended 2026-06-30 |
| FATE | FATE THERAPEUTICS INC | $275.59M | $6.49MTTM ended 2026-06-30 | −$126.00MTTM ended 2026-06-30 |
| IKT | Inhibikase Therapeutics, Inc. | $269.30M | $0.00TTM ended 2025-09-30 | −$60.64MTTM ended 2026-06-30 |
| STRO | SUTRO BIOPHARMA, INC. | $264.80M | $45.70MTTM ended 2026-06-30 | −$180.64MTTM ended 2026-06-30 |
| PALI | PALISADE BIO, INC. | $249.21M | $0.50TTM ended 2026-06-30 | −$31.94MTTM ended 2026-06-30 |
| IVVD | Invivyd, Inc. | $240.82M | $58.37MTTM ended 2026-06-30 | −$107.33MTTM ended 2026-06-30 |
| LCTX | Lineage Cell Therapeutics, Inc. | $227.62M | $13.08MTTM ended 2026-06-30 | −$32.26MTTM ended 2026-06-30 |
| PLX | Protalix BioTherapeutics, Inc. | $215.93M | $80.62MTTM ended 2026-06-30 | $18.95MTTM ended 2026-06-30 |
| ALEC | Alector, Inc. | $207.68M | $13.86MTTM ended 2026-06-30 | −$117.85MTTM ended 2026-06-30 |
| ACOG | Alpha Cognition Inc. | $189.47M | $15.26MTTM ended 2026-06-30 | −$21.01MTTM ended 2026-06-30 |
| CHRS | Coherus Oncology, Inc. | $179.22M | $50.94MTTM ended 2026-06-30 | −$132.13MTTM ended 2026-06-30 |
| AVXL | ANAVEX LIFE SCIENCES CORP. | $175.20M | — | −$13.02MTTM ended 2026-06-30 |
| DTIL | PRECISION BIOSCIENCES INC | $174.72M | $45.05MTTM ended 2026-06-30 | −$52.73MTTM ended 2026-06-30 |
| VYGR | Voyager Therapeutics, Inc. | $165.14M | $34.46MTTM ended 2026-06-30 | −$107.73MTTM ended 2026-06-30 |
| TARA | Protara Therapeutics, Inc. | $163.10M | — | −$70.02MTTM ended 2026-06-30 |
| CMPX | Compass Therapeutics, Inc. | $162.26M | $0.00TTM ended 2025-12-31 | −$73.45MTTM ended 2026-06-30 |
| ABOS | Acumen Pharmaceuticals, Inc. | $149.70M | — | −$105.04MTTM ended 2026-06-30 |
| OTLK | Outlook Therapeutics, Inc. | $139.98M | $1.41MTTM ended 2025-09-30 | −$61.12MTTM ended 2026-06-30 |
| HUMA | Humacyte, Inc. | $139.73M | $2.12MTTM ended 2026-06-30 | −$96.73MTTM ended 2026-06-30 |
| CRBU | Caribou Biosciences, Inc. | $130.79M | $10.04MTTM ended 2026-06-30 | −$103.40MTTM ended 2026-06-30 |
| TNYA | Tenaya Therapeutics, Inc. | $126.91M | — | −$103.11MTTM ended 2026-06-30 |
| ARMP | Armata Pharmaceuticals, Inc. | $123.07M | — | −$192.18MTTM ended 2026-06-30 |
| LENZ | LENZ Therapeutics, Inc. | $119.08M | $21.48MTTM ended 2026-06-30 | −$126.00MTTM ended 2026-06-30 |
| BDTX | Black Diamond Therapeutics, Inc. | $108.01M | $0.00TTM ended 2026-06-30 | −$42.55MTTM ended 2026-06-30 |
| NMRA | Neumora Therapeutics, Inc. | $103.34M | — | −$212.75MTTM ended 2026-06-30 |
| CRDF | Cardiff Oncology, Inc. | $91.80M | $508.00KTTM ended 2026-06-30 | −$40.05MTTM ended 2026-06-30 |
| ATRA | Atara Biotherapeutics, Inc. | $84.92M | $6.19MTTM ended 2026-06-30 | −$16.69MTTM ended 2026-06-30 |
| CGTX | COGNITION THERAPEUTICS INC | $84.73M | — | −$16.77MTTM ended 2026-06-30 |
| PTHS | Pelthos Therapeutics Inc. | $77.91M | $43.30MTTM ended 2026-06-30 | −$86.39MTTM ended 2026-06-30 |
| CSBR | CHAMPIONS ONCOLOGY, INC. | $67.92M | $60.66MTTM ended 2026-07-31 | −$1.14MTTM ended 2026-07-31 |
| KLRS | Kalaris Therapeutics, Inc. | $67.84M | — | −$44.26MTTM ended 2026-06-30 |
| INKT | MiNK Therapeutics, Inc. | $64.96M | — | −$11.36MTTM ended 2026-06-30 |
| INMB | Inmune Bio, Inc. | $53.56M | $50.00KTTM ended 2025-12-31 | −$18.42MTTM ended 2026-06-30 |
| EXOZ | EXOZYMES INC. | $53.46M | — | −$10.19MTTM ended 2026-06-30 |
| IMA | ImageneBio, Inc. | $51.99M | $800.00KTTM ended 2025-12-31 | −$52.48MTTM ended 2026-06-30 |
| TIL | Instil Bio, Inc. | $49.07M | — | −$30.28MTTM ended 2026-06-30 |
| TVGN | Tevogen Bio Holdings Inc. | $43.76M | — | −$21.61MTTM ended 2026-06-30 |
| MGX | Metagenomi Therapeutics, Inc. | $41.74M | $22.33MTTM ended 2026-03-31 | −$93.46MTTM ended 2026-06-30 |
| LONA | LeonaBio, Inc. | $41.27M | — | −$141.46MTTM ended 2026-06-30 |
| SCLX | Scilex Holding Co | $37.45M | $31.61MTTM ended 2026-06-30 | −$464.56MTTM ended 2026-06-30 |
| CVM | CEL SCI CORP | $36.76M | — | −$22.70MTTM ended 2026-06-30 |
| ELUT | ELUTIA INC. | $35.43M | $12.14MTTM ended 2026-06-30 | $51.81MTTM ended 2026-06-30 |
| ALGS | Aligos Therapeutics, Inc. | $34.35M | $3.74MTTM ended 2026-06-30 | −$75.96MTTM ended 2026-06-30 |
| QNCX | Quince Therapeutics, Inc. | $31.20M | — | −$92.48MTTM ended 2026-06-30 |
| ATYR | aTYR PHARMA INC | $28.84M | $190.00KTTM ended 2025-12-31 | −$60.81MTTM ended 2026-06-30 |
| TCRX | TScan Therapeutics, Inc. | $21.55M | $7.11MTTM ended 2026-06-30 | −$117.71MTTM ended 2026-06-30 |
| ESLA | Estrella Immunopharma, Inc. | $20.66M | — | −$10.01MTTM ended 2026-06-30 |
| JSPR | Jasper Therapeutics, Inc. | $19.90M | — | −$31.77MTTM ended 2026-06-30 |
| DYAI | DYADIC INTERNATIONAL INC | $15.67M | $3.80MTTM ended 2026-06-30 | −$7.62MTTM ended 2026-06-30 |
| BCDA | BioCardia, Inc. | $15.44M | $0.00TTM ended 2025-12-31 | −$7.34MTTM ended 2026-06-30 |
| INAB | IN8BIO, INC. | $13.80M | — | −$18.67MTTM ended 2026-06-30 |
| PASG | Passage BIO, Inc. | $13.52M | — | −$36.11MTTM ended 2026-06-30 |
| PLUR | Pluri Inc. | $12.72M | $1.02MTTM ended 2026-06-30 | −$23.82MTTM ended 2026-06-30 |
| INTS | INTENSITY THERAPEUTICS, INC. | $10.48M | — | −$11.16MTTM ended 2026-06-30 |
| SNTI | Senti Biosciences Holdings, Inc. | $10.09M | $55.00KTTM ended 2026-06-30 | −$49.56MTTM ended 2026-06-30 |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | $6.21M | $3.00KTTM ended 2026-06-30 | −$6.04MTTM ended 2026-06-30 |
| AIM | AIM ImmunoTech Inc. | $5.78M | $95.00KTTM ended 2026-06-30 | −$14.27MTTM ended 2026-06-30 |
| LIMN | Liminatus Pharma, Inc. | $5.04M | — | −$12.52MTTM ended 2026-06-30 |
| PMCB | PharmaCyte Biotech, Inc. | $4.34M | $0.00TTM ended 2026-07-31 | −$16.15MTTM ended 2026-07-31 |
| VIVS | VivoSim Labs, INC. | $3.12M | $112.00KTTM ended 2026-06-30 | −$12.34MTTM ended 2026-06-30 |
| CLDI | Calidi Biotherapeutics, Inc. | $2.79M | — | −$17.47MTTM ended 2026-06-30 |
| BCAB | BioAtla, Inc. | $2.10M | — | −$31.45MTTM ended 2026-06-30 |
| CRIS | CURIS INC | $1.73M | $4.31MTTM ended 2026-06-30 | −$21.15MTTM ended 2026-06-30 |
| PHGE | BiomX Inc. | $1.03M | — | −$45.49MTTM ended 2026-06-30 |
| ETRA | Electra Therapeutics, Inc. | — | — | — |
No matching companies.